| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.43B | +1.2% |
| R&D Expense | $152.0M | +0.0% |
| SG&A Expense | $1.98B | +6.3% |
| Operating Income | $2.13B | +6.2% |
| Interest Expense | $217.0M | +18.6% |
| Pre-tax Income | $1.93B | -5.1% |
| Income Tax | $479.0M | +57.0% |
| Net Income | $1.38B | -15.9% |
| EPS (Basic) | $3.52 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.10B | -52.3% |
| Accounts Receivable | $3.69B | +7.6% |
| Inventory | $613.0M | +10.1% |
| Current Assets | $6.50B | -15.2% |
| Total Assets | $10.65B | -5.9% |
| Current Liabilities | $7.66B | -1.2% |
| Long-term Debt | $7.74B | -6.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.60B | +2.1% |
| Investing Cash Flow | -$406.0M | -147.6% |
| Financing Cash Flow | -$2.42B | -683.5% |
| -14.1% |
| EPS (Diluted) | $3.50 | -14.0% |
| Total Liabilities |
| $15.92B |
| -0.7% |
| Stockholders' Equity | -$5.39B | -11.2% |